Steven DuBois, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma (NCT07027748) | Steven DuBois, MD | 2025-06-27 |
Track Steven DuBois, MD automatically
Every clearance here is in the API, with alerts when new ones post.